Forsta Ap Fonden Biomarin Pharmaceutical Inc Transaction History

Forsta Ap Fonden

$11.7 Billion
Q1 2024

A detailed history of Forsta Ap Fonden transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 36,300 shares of BMRN stock, worth $2.98 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

36,300

Previous 32,300 12.38%

Holding current value

$2.98 Million

Previous $3.11 Million 1.8%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$83.81 - $99.0 $335,240 - $396,000	4,000 Added 12.38%	36,300 $3.17 Million
Q4 2023 Feb 06, 2024	SELL	$76.22 - $98.51 $396,344 - $512,252	-5,200 Reduced 13.87%	32,300 $3.11 Million
Q3 2023 Oct 25, 2023	BUY	$85.07 - $94.48 $59,548 - $66,136	700 Added 1.9%	37,500 $3.32 Million
Q2 2023 Aug 03, 2023	SELL	$86.68 - $100.3 $34,672 - $40,120	-400 Reduced 1.08%	36,800 $3.19 Million
Q1 2023 Apr 21, 2023	SELL	$87.74 - $117.27 $526,440 - $703,620	-6,000 Reduced 13.89%	37,200 $3.62 Million

Q4 2022 Feb 02, 2023	BUY	$80.93 - $108.63 $679,812 - $912,492	8,400 Added 24.14%	43,200 $4.47 Million
Q3 2022 Oct 17, 2022	BUY	$82.16 - $96.94 $829,816 - $979,094	10,100 Added 40.89%	34,800 $2.95 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $3.13 Million - $3.8 Million	-43,800 Reduced 63.94%	24,700 $2.05 Million
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $4.25 Million - $5.3 Million	57,200 Added 506.19%	68,500 $5.28 Million
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $2.13 Million - $2.72 Million	-29,700 Reduced 72.44%	11,300 $998,000
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $2.46 Million - $2.81 Million	-32,900 Reduced 44.52%	41,000 $3.17 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $453,060 - $508,740	6,000 Added 8.84%	73,900 $6.17 Million
Q1 2021 May 11, 2021	BUY	$74.73 - $90.69 $2.56 Million - $3.1 Million	34,200 Added 101.48%	67,900 $5.13 Million
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $261,396 - $324,720	-3,600 Reduced 9.65%	33,700 $2.96 Million
Q3 2020 Oct 22, 2020	BUY	$71.87 - $131.03 $668,391 - $1.22 Million	9,300 Added 33.21%	37,300 $2.84 Million
Q2 2020 Aug 11, 2020	BUY	$79.55 - $124.22 $159,100 - $248,440	2,000 Added 7.69%	28,000 $3.45 Million
Q1 2020 May 04, 2020	BUY	$71.37 - $96.85 $1.86 Million - $2.52 Million	26,000 New	26,000 $2.2 Million

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account